Publication Cover
AIDS Care
Psychological and Socio-medical Aspects of AIDS/HIV
Volume 28, 2016 - Issue 11
1,018
Views
49
CrossRef citations to date
0
Altmetric
Articles

Perceived HIV risk, actual sexual HIV risk and willingness to take pre-exposure prophylaxis among men who have sex with men in Toronto, Canada

, , , , , & show all
Pages 1378-1385 | Received 11 Dec 2015, Accepted 12 Apr 2016, Published online: 03 May 2016

References

  • Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … for the Partners PrEP Study Team. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women [Clinical trial, phase III multicenter study randomized controlled trial research support, Non-U.S. Gov’t]. New England Journal of Medicine, 367(5), 399–410. doi:10.1056/NEJMoa1108524
  • Centers for Disease Control and Prevention. (2014). Preexposure prophylaxis for the prevention of HIV infection in the United States – 2014. Clinical Providers’ Supplement. Retrieved March 1, 2016, from http://www.cdc.gov/hiv/pdf/prepprovidersupplement2014.pdf
  • Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., … Vanichseni, S. (2013). Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (The Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet, 381(9883), 2083–2090. doi:10.1016/s0140-6736(13)61127-7
  • Gallagher, T., Link, L., Ramos, M., Bottger, E., Aberg, J., & Daskalakis, D. (2014). Self-perception of HIV risk and candidacy for pre-exposure prophylaxis among men who have sex with men testing for HIV at commercial sex venues in New York City. LGBT Health, 1(3), 218–224. doi: 10.1089/lgbt.2013.0046
  • Gerrard, M., Gibbons, F. X., & Bushman, B. J. (1996). Relation between perceived vulnerability to HIV and precautionary sexual behavior. Psychological Bulletin, 119(3), 390–409. doi: 10.1037/0033-2909.119.3.390
  • Gilead Sciences. (2016). Health Canada issues notice of compliance for Gilead’s Truvada for reducing the risk of sexually acquired HIV infection. Retrieved March 3, 2016, from http://www.newswire.ca/news-releases/health-canada-issues-notice-of-compliance-for-gileads-truvada-for-reducing-the-risk-of-sexually-acquired-hiv-infection-570475811.html
  • Grant, R. M., Anderson, P. L., McMahan, V., Liu, A., Amico, K. R., Mehrotra, M., … Glidden, D. V. (2014). Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study. The Lancet Infectious Diseases, 14(9), 820–829. doi: 10.1016/S1473-3099(14)70847-3
  • Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., … for the iPrEx Study Team. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. New England Journal of Medicine, 363(27), 2587–2599. doi:10.1056/NEJMoa1011205
  • Harrell, F. E. (2001). Regression modeling strategies. With applications to linear models, logistic regression, and survival analysis. New York, NY: Springer-Verlag.
  • Hatcher, L. (1994). A step-by-step approach to using SAS for factor analysis and structural equation modeling. Cary, NC: SAS Institute.
  • Kain, T., Fowler, S., Grennan, T., Hart, T. A., Maxwell, J., Wilton, J., & Tan, D. H. S. (2013). Low perceptions of HIV risk among Toronto MSM seeking anonymous HIV testing: Objective and subjective assessments of PrEP eligibility. Paper presented at the International Association of Providers of AIDS Care (IAPAC), controlling the HIV epidemic with antiretrovirals: Avoiding the cost of inaction, London, UK.
  • Kesler, M. A., Kaul, R., Liu, J., Loutfy, M., Gesink, D., Myers, T., & Remis, R. S. (2016). Actual sexual risk and perceived risk of HIV acquisition among HIV-negative men who have sex with men in Toronto, Canada. BMC Public Health, 16(1), 3. doi:10.1186/s12889-016-2859-6
  • Koh, K. C., & Yong, L. S. (2014). HIV risk perception, sexual behavior, and HIV prevalence among men-who-have-sex-with-men at a community-based voluntary counseling and testing center in Kuala Lumpur, Malaysia. Interdisciplinary Perspectives on Infectious Diseases, 2014, article id 236240. doi: 10.1155/2014/236240
  • Leonardi, M., Lee, E., & Tan, D. H. S. (2011). Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown Toronto, Canada [Research Support, Non-U.S. Gov’t]. International Journal of STD & AIDS, 22(12), 738–741. doi: 10.1258/ijsa.2011.011057
  • Liu, J., Remis, R. S., Loutfy, M., Tharao, W., Rebbapragada, A., Halpenny, R., … Kaul, R. (2014, May 1–4). Prevalence and correlates of sexually transmitted co-infections in HIV-positive and HIV-negative men who have sex with men in Toronto. Poster session P105 presented at the meeting of Canadian Conference on HIV/AIDS Research (CAHR), St John's, Newfoundland and Labrador, Canada.
  • Mayer, K. H., Ducharme, R., Zaller, N. D., Chan, P. A., Case, P., Abbott, D., … Cavanaugh, T. (2012). Unprotected sex, underestimated risk, undiagnosed HIV and sexually transmitted diseases among men who have sex with men accessing testing services in a New England bathhouse. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59, 194–198. doi: 10.1097/QAI.0b013e31823bbecf
  • McCormack, S. (2015). Pragmatic open-label randomized trial of pre-exposure prophylaxis: The PROUD study. Paper presented at the conference on retroviruses and opportunistic infections (CROI), Seattle, Washington, USA.
  • Ministere de la Sante at des Services Sociaux. (2013). Avis interimaire, sur la prophylaxie preexposition au virus de l'immunodeficience humaine. Gouvernement du Québec. Retrieved from http://publications.msss.gouv.qc.ca/msss/document-000313.
  • Molina, J. M., Capitant, C., Charreau, I., Meyer, L., Spire, B., Pialoux, G., … Tremblay, C. (2015). On demand PrEP with oral TDF-FTC in MSM: Results of the ANRS Ipergay Trial. Paper presented at the conference on retroviruses and opportunistic infections (CROI), Seattle, Washington.
  • Mutchler, M. G., McDavitt, B., Ghani, M. A., Nogg, K., Winder, T. J., & Soto, J. K. (2015). Getting prepared for HIV prevention navigation: Young black Gay Men talk about HIV prevention in the biomedical era [Research Support, N.I.H., Extramural]. AIDS Patient Care and STDs, 29(9), 490–502. doi:10.1089/apc.2015.0002
  • Prata, N., Morris, L., Mazive, E., Vahidnia, F., & Stehr, M. (2006). Relationship between HIV risk perception and condom use: Evidence from a population-based survey in Mozambique. International Family Planning Perspectives, 32(4), 192–200. doi:10.1363/ifpp.32.192.06
  • Smith, D. K., Pals, S. L., Herbst, J. H., Shinde, S., & Carey, J. W. (2012). Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States. JAIDS Journal of Acquired Immune Deficiency Syndromes, 60(4), 421–427. doi: 10.1097/QAI.0b013e318256b2f6
  • Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., … for the TDF2 Study Group. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana [Clinical trial, phase III Multicenter study randomized controlled trial research support, N.I.H., extramural research support, U.S. Gov’t, P.H.S.]. New England Journal of Medicine, 367(5), 423–434. doi:10.1056/NEJMoa1110711
  • U.S. Food and Drug Administration. (2012). FDA approves first drug for reducing the risk of sexually acquired HIV infection. Retrieved August 20, 2014 from http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm312210.htm
  • US Public Health Service. (2014). Preexposure prophylaxis for the prevention of HIV infection in the United States 2014. A clinical practice guideline (pp. 1–67). Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.